Literature DB >> 22542464

Common and specific liability to addiction: approaches to association studies of opioid addiction.

David A Nielsen1, Mary Jeanne Kreek.   

Abstract

BACKGROUND: Opioid addiction, whether to opiates such as heroin and morphine, and/or to non-medical use of opioids, is a major problem worldwide. Although drug-induced and environmental factors are essential for the liability to develop opioid addiction, the genetic background of an individual is now known also to play a substantial role.
METHODS: The overall goal of this article is to address the common and specific liabilities to addiction in the context of approaches to studies of one addiction, opioid addiction. Literature on identifying genetic variants that may play a role in the development of opioid addiction was reviewed.
RESULTS: A substantial number of genetic variants have been reported to be associated with opioid addiction. No single variant has been found in any of the reported GWAS studies with a substantial effect size on the liability to develop heroin addiction. It appears that there is a complex interaction of a large number of variants, some rare, some common, which interact with the environment and in response to specific drugs of abuse to increase the liability of developing opioid addiction.
CONCLUSIONS: In spite of the inherent difficulties in obtaining large well-phenotyped cohorts for genetic studies, new findings have been reported that are being used to develop testable hypotheses into the biological basis of opioid addiction.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542464      PMCID: PMC3689423          DOI: 10.1016/j.drugalcdep.2012.03.026

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  112 in total

1.  RNA exosome depletion reveals transcription upstream of active human promoters.

Authors:  Pascal Preker; Jesper Nielsen; Susanne Kammler; Søren Lykke-Andersen; Marianne S Christensen; Christophe K Mapendano; Mikkel H Schierup; Torben Heick Jensen
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

2.  Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.

Authors:  Leighton J Core; Joshua J Waterfall; John T Lis
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

3.  Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.

Authors:  Beben Benyamin; Allan F McRae; Gu Zhu; Scott Gordon; Anjali K Henders; Aarno Palotie; Leena Peltonen; Nicholas G Martin; Grant W Montgomery; John B Whitfield; Peter M Visscher
Journal:  Am J Hum Genet       Date:  2008-12-11       Impact factor: 11.025

4.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

5.  Divergent transcription from active promoters.

Authors:  Amy C Seila; J Mauro Calabrese; Stuart S Levine; Gene W Yeo; Peter B Rahl; Ryan A Flynn; Richard A Young; Phillip A Sharp
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

6.  Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.

Authors:  Bronson E Oosterhuis; K Steven LaForge; Dmitri Proudnikov; Ann Ho; David A Nielsen; Robert Gianotti; Sandra Barral; Derek Gordon; Suzanne M Leal; Jurg Ott; Mary Jeanne Kreek
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

7.  Genetic susceptibility to heroin addiction: a candidate gene association study.

Authors:  O Levran; D Londono; K O'Hara; D A Nielsen; E Peles; J Rotrosen; P Casadonte; S Linzy; M Randesi; J Ott; M Adelson; M J Kreek
Journal:  Genes Brain Behav       Date:  2008-06-02       Impact factor: 3.449

8.  Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA.

Authors:  A Knafo; S Israel; A Darvasi; R Bachner-Melman; F Uzefovsky; L Cohen; E Feldman; E Lerer; E Laiba; Y Raz; L Nemanov; I Gritsenko; C Dina; G Agam; B Dean; G Bornstein; R P Ebstein
Journal:  Genes Brain Behav       Date:  2007-08-13       Impact factor: 3.449

Review 9.  Small silencing RNAs: an expanding universe.

Authors:  Megha Ghildiyal; Phillip D Zamore
Journal:  Nat Rev Genet       Date:  2009-02       Impact factor: 53.242

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  12 in total

1.  Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence.

Authors:  Shabnam Azadeh; Brian P Hobbs; Liangsuo Ma; David A Nielsen; F Gerard Moeller; Veerabhadran Baladandayuthapani
Journal:  Neuroimage       Date:  2015-10-17       Impact factor: 6.556

Review 2.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

Review 3.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

4.  Negative reinforcement via motivational withdrawal is the driving force behind the transition to addiction.

Authors:  Olivier George; George F Koob; Leandro F Vendruscolo
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

5.  Identification of a sex-stratified genetic algorithm for opioid addiction risk.

Authors:  David Bright; Anna Langerveld; Susan DeVuyst-Miller; Claire Saadeh; Ashley Choker; Elisabeth Lehigh; Stephanie Wheeler; Ahed Zayzafoon; Minji Sohn
Journal:  Pharmacogenomics J       Date:  2021-02-15       Impact factor: 3.550

6.  Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment.

Authors:  Pier Paolo Pani; Emanuela Trogu; Federica Vigna-Taglianti; Federica Mathis; Roberto Diecidue; Ursula Kirchmayer; Laura Amato; Marina Davoli; Joli Ghibaudi; Antonella Camposeragna; Alessio Saponaro; Fabrizio Faggiano; Angelo Giovanni Icro Maremmani; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2014-11-18       Impact factor: 3.455

Review 7.  Toward the Identification of a Specific Psychopathology of Substance Use Disorders.

Authors:  Angelo G I Maremmani; Pier Paolo Pani; Luca Rovai; Silvia Bacciardi; Icro Maremmani
Journal:  Front Psychiatry       Date:  2017-04-27       Impact factor: 4.157

8.  Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

Authors:  Laura R Lander; Vincent Setola; Shane W Kaski; Stephan Brooks; Sijin Wen; Marc W Haut; David P Siderovski; James H Berry
Journal:  J Opioid Manag       Date:  2019 Mar-Apr

Review 9.  Rat Ultrasonic Vocalizations and Behavioral Neuropharmacology: From the Screening of Drugs to the Study of Disease.

Authors:  Nicola Simola
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Morphine induces albuminuria by compromising podocyte integrity.

Authors:  Xiqian Lan; Partab Rai; Nirupama Chandel; Kang Cheng; Rivka Lederman; Moin A Saleem; Peter W Mathieson; Mohammad Husain; John T Crosson; Kalpna Gupta; Ashwani Malhotra; Pravin C Singhal
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.